Trials / Conditions / Recurrent Adenoid Cystic Carcinoma
Recurrent Adenoid Cystic Carcinoma
4 registered clinical trials studyying Recurrent Adenoid Cystic Carcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRA NCT07521670 | National Cancer Centre, Singapore | Phase 2 |
| Recruiting | Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma NCT06118086 | Remix Therapeutics | Phase 1 / Phase 2 |
| Recruiting | CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC NCT05774899 | Glenn J. Hanna | Phase 1 / Phase 2 |
| Completed | Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma NCT03990571 | M.D. Anderson Cancer Center | Phase 2 |